Atlas Trials

Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC

Clinical trial NCT02407171 · COMPLETED

Trial details

NCT number
NCT02407171
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
MelanomaLung Cancer
Start date
2015-04-01
Primary completion
2019-02-19
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.